Detalhe da pesquisa
1.
Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis.
Blood
; 141(21): 2615-2628, 2023 05 25.
Artigo
Inglês
| MEDLINE | ID: mdl-36735903
2.
Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study.
Blood
; 142(17): 1438-1447, 2023 10 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37418685
3.
The role of baseline 2-[18 F]-FDG-PET/CT metrics and radiomics features in predicting primary gastric lymphoma diagnosis.
Hematol Oncol
; 42(2): e3266, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38444261
4.
2-[18]F FDG PET/CT dissemination features in adult burkitt lymphoma Are predictive of outcome.
Ann Hematol
; 2024 Feb 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38374254
5.
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi.
Br J Haematol
; 201(4): 653-662, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36733229
6.
Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88.
Blood
; 137(18): 2495-2508, 2021 05 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33197938
7.
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity.
Blood
; 138(18): 1705-1720, 2021 11 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34077955
8.
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL).
Haematologica
; 108(4): 1083-1091, 2023 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36384247
9.
COVID-19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantation.
Hematol Oncol
; 41(3): 555-558, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36786526
10.
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.
Hematol Oncol
; 41(1): 78-87, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36177902
11.
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study.
Br J Haematol
; 199(1): 54-60, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35906881
12.
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial.
Br J Haematol
; 196(5): 1184-1193, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34951009
13.
Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome.
Haematologica
; 107(5): 1153-1162, 2022 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34289655
14.
The safety and clinical effectiveness of rapid infusion with CT-P10 in patients with non-Hodgkin's lymphoma or chronic lymphocytic leukemia: A retrospective non-interventional post-authorization safety study in Europe.
Hematol Oncol
; 40(3): 370-380, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35168291
15.
The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
Ann Hematol
; 101(6): 1227-1237, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35380239
16.
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL).
Br J Haematol
; 193(2): 280-289, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33476434
17.
Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19.
Cancer
; 126(23): 5069-5076, 2020 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32910456
18.
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Lancet
; 394(10216): 2271-2281, 2019 12 21.
Artigo
Inglês
| MEDLINE | ID: mdl-31868632
19.
An increase in MYC copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimens.
Haematologica
; 105(5): 1369-1378, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31399522
20.
Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia.
Hematol Oncol
; 38(5): 754-762, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-32950042